UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Mutated thyroid hormone transporter OATP1C1 associates with severe brain hypometabolism and juvenile neurodegeneration

Stromme, P; Groeneweg, S; Lima de Souza, EC; Zevenbergen, C; Torgersbråten, A; Holmgren, A; Gurcan, E; ... Visser, TJ; + view all (2018) Mutated thyroid hormone transporter OATP1C1 associates with severe brain hypometabolism and juvenile neurodegeneration. Thyroid , 28 (11) pp. 1406-1415. 10.1089/thy.2018.0595. Green open access

[thumbnail of Zetterberg_Strømme.pdf]
Preview
Text
Zetterberg_Strømme.pdf - Accepted Version

Download (911kB) | Preview

Abstract

Context Thyroid hormones (TH) are essential for brain development and function. The TH transporters monocarboxylate transporter 8 (MCT8) and organic anion transporter1 C1 (OATP1C1) facilitate the transport of TH across the blood-brain-barrier and into glia and neuronal cells in the brain. Loss of MCT8 function causes Allan-Herndon-Dudley syndrome (AHDS, OMIM 300523) characterized by severe intellectual and motor disability due to cerebral hypothyroidism. We describe the first patient with loss of OATP1C1 function. The patient is a 15.5-year-old girl with normal development in the first year of life, who gradually developed dementia with spasticity and intolerance to cold. Brain imaging demonstrated grey and white matter degeneration and severe glucose hypometabolism. Methods We performed exome sequencing of the patient and parents to identify the disease-causing mutation and studied the effect of the mutation through a panel of in vitro experiments, including T4 uptake studies, immunoblotting, and immunocytochemistry. Furthermore, we describe the clinical effects of treatment with the T3 analogue triiodothyroacetic acid (Triac). Results Exome sequencing identified a homozygous missense mutation in OATP1C1 changing the highly conserved aspartic acid 252 to asparagine (D252N). In vitro, the mutated OATP1C1 displays impaired plasma membrane localization and decreased cellular T4 uptake. After treatment with Triac the clinical condition improved in several domains. Conclusions This is the first report of human OATP1C1 deficiency, compatible with brain-specific hypothyroidism and neurodegeneration.

Type: Article
Title: Mutated thyroid hormone transporter OATP1C1 associates with severe brain hypometabolism and juvenile neurodegeneration
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1089/thy.2018.0595
Publisher version: https://doi.org/10.1089/thy.2018.0595
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery.ucl.ac.uk/id/eprint/10061204
Downloads since deposit
Loading...
162Downloads
Download activity - last month
Loading...
Download activity - last 12 months
Loading...
Downloads by country - last 12 months
Loading...

Archive Staff Only

View Item View Item